KAYLIN WALTERS: Open Payments
NPI 1164045142 · GRAND RAPIDS, MI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,232 in 57 payments from 16 companies in 2025. Trend: 2023 $616 · 2024 $298 · 2025 $1,232
Food & beverage: $1,232
| Company | Payments | Amount |
|---|---|---|
| Amgen Inc. | 14 | $297 |
| E.R. Squibb & Sons, L.L.C. | 12 | $135 |
| Medtronic, Inc. | 2 | $127 |
| Alnylam Pharmaceuticals Inc. | 5 | $98 |
| Bayer Healthcare Pharmaceuticals Inc. | 4 | $89 |
| Baxter Healthcare | 2 | $89 |
| Novartis Pharmaceuticals Corporation | 3 | $75 |
| Merck Sharp & Dohme LLC | 3 | $69 |
| Novo Nordisk Inc | 2 | $53 |
| PFIZER INC. | 2 | $51 |
Products named: REPATHA, AURORA EV-ICD MRI SURESCAN, ONPATTRO, Kerendia, CAMZYOS, LEQVIO, Hillrom - Carnation Ambulatory Monitor, ELIQUIS.
Industry payments across MI — which companies pay providers there.
